Target intelligence / Profile preview

Wilms' Tumor Protein 1 (WT1)

Target
WT1
Molecular classification
Transcription factor
01

Overview

Wilms' tumor protein, commonly referred to as WT1, is a transcription factor encoded by the WT1 gene. It plays a critical role in the development of the urogenital system and is essential for normal kidney formation. Mutations or deletions in this gene are associated with Wilms' tumor and other developmental syndromes. WT1 acts as a transcription factor regulating genes involved in cell differentiation, epithelial/mesenchymal transition control, cell proliferation, and apoptosis. It has both tumor suppressor and oncogenic roles depending on the cellular context.

Other names
Wilms Tumor 1WT-1
02

Mechanism of action

Currently, there are no drugs directly targeting WT1. Research focuses on inhibiting WT1 expression or function indirectly through other pathways.

03

Biological functions

Transcriptional regulationCell differentiationEpithelial/mesenchymal transition controlCell proliferationApoptosisKidney developmentUrogenital developmentHematopoiesis
04

Disease associations

Wilms’ tumorDenys–Drash syndromeFrasier syndromeWAGR syndromeCancer
05

Safety considerations

Potential for off-target effects due to broad expression during development and in certain adult tissues.Complex role in both tumor suppression and oncogenesis makes therapeutic targeting challenging.
06

Biomarkers

WT1 expression in tumor tissueWT1 mutations

Beyond the preview

Go deeper on Wilms' Tumor Protein 1 (WT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wilms' Tumor Protein 1 (WT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call